All In MedTech

Device type · NOE

Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about NOE: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 20, 2026Source: openFDAMethods & limitations

How FDA classifies it

Device type
Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2
Product code
NOE
Device class
Class II
Review panel
Immunology
Regulation
21 CFR 866.5600

Latest FDA decisions

All decisions for NOE

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor

No reports to chart for this view.

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

No manufacturers to rank.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

No device problems coded.

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

No patient problems coded.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

11 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.